Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

New class of antifungal agents developed at Glaxo Wellcome

Sep. 30, 1997

PathoGenesis presents new antimycobacterial agents

Sep. 30, 1997

Antiviral thienoxazinones prepared at SKB

Sep. 30, 1997

Zeneca presents new antibacterials active against resistant pathogens

Sep. 30, 1997

Improved oxazolidinone prodrugs reported at ICAAC

Sep. 29, 1997

New oxazolidinone from P&U described at ICAAC

Sep. 29, 1997

Phosphomannose isomerase as target for antifungal drugs

Sep. 29, 1997

Glaxo Wellcome describes new agents for CMV

Sep. 29, 1997

Schering-Plough and Genome Therapeutics enter antifungal alliance

Sep. 26, 1997

Phase III trial of Neuprex in meningococcemia continues; pilot trial in CF begins

Sep. 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...